Willow Biosciences Inc (TSE:WLLW) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Willow Biosciences Inc. announces a strategic partnership with Laurus Labs for the development and manufacturing of active pharmaceutical ingredients, forecasting significant revenue growth with over $1 million expected in Q2 and more than $3.5 million in 2024. The company is also expanding its technological capabilities with the appointment of AI and industry experts Dr. Richard Fox and Mr. Gregory Rocklin, and adding a new program in the burgeoning biopesticide market. Additionally, Willow has secured its first patent and plans to file five more in 2024, focusing on steroid production technology.
For further insights into TSE:WLLW stock, check out TipRanks’ Stock Analysis page.
